Thetford Mines, Quebec – June 26, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce that Dr. Giuseppe D’Aprano is appointed to the Corporation’s management team as Chief Scientific Officer (CSO) as of June 26, 2019.
- KDA Group has signed a letter of intent for the acquisition of CONSUTLANDGROW
- KDA Group annouces definitive closing of private placement
- KDA Group annouces the appointment of Dr Giuseppe D’Aprano as Chief Scientific Officer
- KDA Group completes previously announced sales of a majority stake in Pharmapar
- KDA Group signed a share purchase agreement with Strides for the sales of majority stake in Pharmapar